Cargando…
Multivalent Antiviral XTEN–Peptide Conjugates with Long in Vivo Half-Life and Enhanced Solubility
[Image: see text] XTENs are unstructured, nonrepetitive protein polymers designed to prolong the in vivo half-life of pharmaceuticals by introducing a bulking effect similar to that of poly(ethylene glycol). While XTEN can be expressed as a recombinant fusion protein with bioactive proteins and pept...
Autores principales: | Ding, Sheng, Song, Michael, Sim, Bee-Cheng, Gu, Chen, Podust, Vladimir N., Wang, Chia-Wei, McLaughlin, Bryant, Shah, Trishul P, Lax, Rodney, Gast, Rainer, Sharan, Rahul, Vasek, Arthur, Hartman, M. Amanda, Deniston, Colin, Srinivas, Prathna, Schellenberger, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157762/ https://www.ncbi.nlm.nih.gov/pubmed/24932887 http://dx.doi.org/10.1021/bc500215m |
Ejemplares similares
-
GLP2-2G-XTEN: A Pharmaceutical Protein with Improved Serum Half-Life and Efficacy in a Rat Crohn’s Disease Model
por: Alters, Susan E., et al.
Publicado: (2012) -
Correction: GLP2-2G-XTEN: A Pharmaceutical Protein with Improved Serum Half-Life and Efficacy in a Rat Crohn’s Disease Model
por: Alters, Susan E., et al.
Publicado: (2013) -
XTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based Cytostatic
por: Haeckel, Akvile, et al.
Publicado: (2016) -
Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications
por: Haeckel, Akvile, et al.
Publicado: (2021) -
Gcg-XTEN: An Improved Glucagon Capable of Preventing Hypoglycemia without Increasing Baseline Blood Glucose
por: Geething, Nathan C., et al.
Publicado: (2010)